SCHEMBL9343960

SCHEMBL9343960

COC(=O)C(N)Cc1cc(CP(=O)(O)O)cc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.38
▸ ROCK2 O75116 1/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ GRIN2D O15399 1/20 0.37
▸ GRIN3B O60391 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ GRIN2C Q14957 1/20 0.37
▸ GRIN3A Q8TCU5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348521 0.87 MEN1 (0.39) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9344811 0.85 MEN1 (0.69) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345161 0.85 MEN1 (0.56) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL539261 0.81 ROCK2 (0.52) CYP2C19ALDH1A1ROCK2CYP1A2CYP2C9
SCHEMBL539262 0.81 ROCK2 (0.52) CYP2C19ALDH1A1ROCK2CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL539617 0.80 ROCK2 (0.51) CYP2C19ALDH1A1ROCK2CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL539618 0.80 ROCK2 (0.51) CYP2C19ALDH1A1ROCK2CYP1A2CYP2C9
SCHEMBL9343957 0.80 MEN1 (0.53) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9345165 0.80 MEN1 (0.53) MEN1ALOX15CYP2C19KMT2AHSD17B10
SCHEMBL9343956 0.79 TDP1 (0.40) MEN1ALOX15CYP2C19KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5321016-A Epliepsy, central nervous system disorders SANDOZ PHARMACEUTICALS CORP. (US) 1994-06-14 — — US disclosed
US-5162311-A Treating epilepsy, psychiatric disorders SANDOZ PHARMACEUTICALS CORP. (US) 1992-11-10 — — US disclosed
Send feedback